{'fraction_non_alphanumeric': 0.024051803885291396, 'fraction_numerical': 0.0, 'mean_word_length': 5.7625, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Experience in the treatment of normogonadotropic infertility in men].

This study presents an experience of application of follicle-stimulating drug in the treatment of men with normogonadotropic infertility. Patients of the study group have received standard treatment, including multivitamins, and additionally received follitropin-alpha (Gonal-f). They also underwent ultraviolet blood irradiation. Patients of comparison group were treated according to a standard scheme. All men underwent standard clinical and laboratory examination. The therapy consisting of follitropin alpha and ultraviolet blood irradiation in patients with infertility normalizes the function of endocrine glands, as indicated by an increase of testosterone levels, and decrease of prolactin and FSH levels. Moreover, there is a marked stimulation of spermatogenesis, as evidenced by a significant increase in the number of active sperm. The results of this study allow to recommend follitropin-alpha (Gonal-f) and ultraviolet blood irradiation for the correction of normogonadotropic treatment in men.